| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/QAI.0B013E3182354E65 |
| P8608 | Fatcat ID | release_yn5tzcjrjvavrg2ye6kbjbstea |
| P698 | PubMed publication ID | 21909032 |
| P50 | author | Agnes Binagwaho | Q4693015 |
| P2093 | author name string | Anita Asiimwe | |
| Jean Paul Bitega | |||
| Theobald Hategekimana | |||
| Muyenzi Leon Ngeruka | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention of HIV/AIDS | Q7242372 |
| P304 | page(s) | e127-34 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings | |
| P478 | volume | 58 |
| Q36037814 | A Cross Sectional Study of the Prevalence of Preputial and Penile Scrotal Abnormalities among Clients Undergoing Voluntary Medical Male Circumcision in Soweto, South Africa |
| Q36030235 | A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex™ Device to Forceps Guided Surgical Circumcision in Zimbabwe |
| Q27345073 | A fast, easy circumcision procedure combining a CO2 laser and cyanoacrylate adhesive: a non-randomized comparative trial |
| Q37074207 | Acceptability and Satisfaction Associated With the Introduction of the PrePex Circumcision Device in Maputo, Mozambique |
| Q37525468 | Adverse events profile of PrePex a non-surgical device for adult male circumcision in a Ugandan urban setting |
| Q21034183 | Assessing Odor Level when Using PrePex for HIV Prevention: A Prospective, Randomized, Open Label, Blinded Assessor Trial to Improve Uptake of Male Circumcision |
| Q35116432 | Community and healthcare providers' perspectives on male circumcision: a multi-centric qualitative study in India |
| Q37074197 | Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique |
| Q33572206 | Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe |
| Q35655257 | Design, testing, and scale-up of medical devices for global health: negative pressure wound therapy and non-surgical male circumcision in Rwanda |
| Q37699117 | Evidence-based identification of key beliefs explaining adult male circumcision motivation in Zimbabwe: targets for behavior change messaging |
| Q34531643 | Factors Associated With Delayed Healing in a Study of the PrePex Device for Adult Male Circumcision in Kenya |
| Q47738878 | Implementing voluntary medical male circumcision using an innovative, integrated, health systems approach: experiences from 21 districts in Zimbabwe |
| Q37074375 | Innovative Methods of Male Circumcision for HIV Prevention-Getting the Right Evidence |
| Q30276920 | Making voluntary medical male circumcision a viable HIV prevention strategy in high prevalence countries by engaging the traditional sector |
| Q28300040 | Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections |
| Q36812534 | Overview of the current state of the epidemic |
| Q39664295 | Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana |
| Q35785128 | PrePex Male Circumcision: Follow-Up and Outcomes during the First Two Years of Implementation at the Rwanda Military Hospital. |
| Q36475979 | Psychosocial Results from a Phase I Trial of a Nonsurgical Circumcision Device for Adult Men in Zimbabwe |
| Q34743899 | Reach and cost-effectiveness of the PrePex device for safe male circumcision in Uganda |
| Q91756277 | Reducing Provider Workload While Preserving Patient Safety: A Randomized Control Trial Using 2-Way Texting for Postoperative Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program |
| Q37074234 | Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe |
| Q37074227 | Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe |
| Q37074211 | Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia |
| Q37662296 | Safety and efficacy of a novel disposable circumcision device: a pilot randomized controlled clinical trial at 2 centers |
| Q47268793 | Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe |
| Q37074222 | Safety, Feasibility, and Acceptability of the PrePex Device for Adult Male Circumcision in Malawi |
| Q33553772 | Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya |
| Q37467054 | Techniques of male circumcision |
| Q34562179 | The PrePex device is unlikely to achieve cost-savings compared to the forceps-guided method in male circumcision programs in sub-Saharan Africa |
| Q37248549 | The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda |
| Q34075127 | The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study |
| Q92616514 | Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
| Q38385581 | Voluntary medical male circumcision in resource-constrained settings |
| Q24621413 | Voluntary medical male circumcision: an HIV prevention priority for PEPFAR |
| Q21563036 | Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up |
Search more.